The more I read this, the more distasteful the proposed grant of these options is:
- exercise price at 97c;
- 5 year expiry;
- cashless exercise facility; and
- no performance targets.
These options should have an exercise price of $2+ given the lengthy term, progress since Paul Wotton was granted 2 million options with an exercise price at $1.50 in 2017, and availability of a cashless exercise facility where they don't necessarily have to stump up any of their own money.
Every time the share price starts to rise, they find a way to curtail it with greed or incompetence. It's time to DELIVER to EXPECTATION.
I will be voting no to all option resolutions, except that for Darryl Maher who needs to be incentivised given that he's recently joined, carries a significant reputation and has the potential to change the Company's self-entitled culture.
DYOR, IMO only, GLTAH
- Forums
- ASX - By Stock
- CYP
- Ann: Appendix 3G
CYP
cynata therapeutics limited
Add to My Watchlist
20.0%
!
18.0¢

Ann: Appendix 3G, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.0¢ |
Change
0.030(20.0%) |
Mkt cap ! $41.80M |
Open | High | Low | Value | Volume |
15.5¢ | 18.5¢ | 15.5¢ | $178.5K | 1.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 106671 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 569 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 106671 | 0.170 |
1 | 152000 | 0.160 |
4 | 45350 | 0.155 |
5 | 145379 | 0.150 |
7 | 195775 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 569 | 1 |
0.190 | 8000 | 2 |
0.195 | 63524 | 3 |
0.200 | 56400 | 3 |
0.220 | 14548 | 2 |
Last trade - 12.05pm 18/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |